Skip to main content
Log in

Heterogeneity of circulating CXCR5-PD-1hiTph cells in patients of type 2 and type 1 diabetes in Chinese population

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

Aims

Circulating peripheral helper T (Tph) cells are shown to promote the progression of autoimmune diseases. However, the role of Tph cells in inflammatory diseases such as type 2 diabetes mellitus (T2DM) and the differences between T2DM and autoimmune diabetes remain unclear.

Methods

We recruited 92 T2DM patients, 106 type 1 diabetes mellitus (T1DM) patients and 84 healthy control individuals. Peripheral blood mononucleated cells were isolated and examined by multicolor flow cytometry. We further evaluated the correlations between circulating Tph cells and clinical biochemical parameters, islet function, disease progression and islet autoantibodies.

Results

Circulating Tph cells were significantly higher in both T2DM and T1DM patients than in healthy control individuals. A significant positive correlation was observed between Tph cells and B cells in T1DM patients and overweight T2DM patients. Furthermore, Tph cells were negatively correlated with the area under the C-peptide curve (C-PAUC), and Tph cells were significantly positively correlated with fasting glucose and glycated hemoglobin levels in T2DM patients. However, no correlation was found between Tph cells and the above clinical indicators in T1DM patients. The frequency of Tph cells positively correlated with the titer of GAD autoantibodies and duration of disease in T1DM patients. In addition, we demonstrated that the frequency of Tph cells was decreased after rituximab therapy in T1DM patients.

Conclusions

Circulating Tph cells are associated with blood glucose levels and islet function in T2DM patients. In T1DM patients, circulating Tph cells are associated with B cells and islet autoantibodies. This may suggest that Tph cells have different pathogenic mechanisms in the two types of diabetes.

Clinical trial information

http://ClinicalTrials.gov NCT01280682 (registered July, 2010).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

The datasets generated and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.

References

  1. Donath MY, Schumann DM, Faulenbach M, Ellingsgaard H, Perren A, Ehses JA (2008) Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care 31(Suppl 2):S161-164. https://doi.org/10.2337/dc08-s243

    Article  CAS  PubMed  Google Scholar 

  2. Donath MY, Böni-Schnetzler M, Ellingsgaard H, Ehses JA (2009) Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes. Physiology (Bethesda) 24:325–331. https://doi.org/10.1152/physiol.00032.2009

    Article  CAS  PubMed  Google Scholar 

  3. Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98–107. https://doi.org/10.1038/nri2925

    Article  CAS  PubMed  Google Scholar 

  4. Brooks-Worrell B, Palmer JP (2012) Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation. Clin Exp Immunol 167:40–46. https://doi.org/10.1111/j.1365-2249.2011.04501.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85–97. https://doi.org/10.1038/nri2921

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Asghar A, Sheikh N (2017) Role of immune cells in obesity induced low grade inflammation and insulin resistance. Cell Immunol 315:18–26. https://doi.org/10.1016/j.cellimm.2017.03.001

    Article  CAS  PubMed  Google Scholar 

  7. SantaCruz-Calvo S, Bharath L, Pugh G, SantaCruz-Calvo L, Lenin RR, Lutshumba J et al (2022) Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities. Nat Rev Endocrinol 18:23–42. https://doi.org/10.1038/s41574-021-00575-1

    Article  CAS  PubMed  Google Scholar 

  8. McLaughlin T, Liu LF, Lamendola C, Shen L, Morton J, Rivas H et al (2014) T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans. Arterioscler Thromb Vasc Biol 34:2637–2643. https://doi.org/10.1161/atvbaha.114.304636

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Goel A, Chiu H, Felton J, Palmer JP, Brooks-Worrell B (2007) T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes. Diabetes 56:2110–2115. https://doi.org/10.2337/db06-0552

    Article  CAS  PubMed  Google Scholar 

  10. Brooks-Worrell BM, Boyko EJ, Palmer JP (2014) Impact of islet autoimmunity on the progressive β-cell functional decline in type 2 diabetes. Diabetes Care 37:3286–3293. https://doi.org/10.2337/dc14-0961

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Rao DA, Gurish MF, Marshall JL, Slowikowski K, Fonseka CY, Liu Y et al (2017) Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature 542:110–114. https://doi.org/10.1038/nature20810

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Fortea-Gordo P, Nuño L, Villalba A, Peiteado D, Monjo I, Sánchez-Mateos P et al (2019) Two populations of circulating PD-1hiCD4 T cells with distinct B cell helping capacity are elevated in early rheumatoid arthritis. Rheumatology (Oxford) 58:1662–1673. https://doi.org/10.1093/rheumatology/kez169

    Article  CAS  PubMed  Google Scholar 

  13. Yoshitomi H, Ueno H (2021) Shared and distinct roles of T peripheral helper and T follicular helper cells in human diseases. Cell Mol Immunol 18:523–527. https://doi.org/10.1038/s41423-020-00529-z

    Article  CAS  PubMed  Google Scholar 

  14. Wacleche VS, Wang R, Rao DA (2022) Identification of T Peripheral Helper (Tph) Cells. Methods Mol Biol 2380:59–76. https://doi.org/10.1007/978-1-0716-1736-6_6

    Article  CAS  PubMed  Google Scholar 

  15. Rao DA (2018) T Cells That Help B Cells in Chronically Inflamed Tissues. Front Immunol 9:1924. https://doi.org/10.3389/fimmu.2018.01924

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Bocharnikov AV, Keegan J, Wacleche VS, Cao Y, Fonseka CY, Wang G, et al. (2019) PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21. JCI Insight 4. https://doi.org/10.1172/jci.insight.130062

  17. Verstappen GM, Meiners PM, Corneth OBJ, Visser A, Arends S, Abdulahad WH et al (2017) Attenuation of Follicular Helper T Cell-Dependent B Cell Hyperactivity by Abatacept Treatment in Primary Sjögren’s Syndrome. Arthritis Rheumatol 69:1850–1861. https://doi.org/10.1002/art.40165

    Article  CAS  PubMed  Google Scholar 

  18. Yabe H, Kamekura R, Yamamoto M, Murayama K, Kamiya S, Ikegami I et al (2021) Cytotoxic Tph-like cells are involved in persistent tissue damage in IgG4-related disease. Mod Rheumatol 31:249–260. https://doi.org/10.1080/14397595.2020.1719576

    Article  CAS  PubMed  Google Scholar 

  19. Wang X, Li T, Si R, Chen J, Qu Z, Jiang Y (2020) Increased frequency of PD-1(hi)CXCR5(-) T cells and B cells in patients with newly diagnosed IgA nephropathy. Sci Rep 10:492. https://doi.org/10.1038/s41598-019-57324-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Choi JY, Ho JH, Pasoto SG, Bunin V, Kim ST, Carrasco S et al (2015) Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. Arthritis Rheumatol 67:988–999. https://doi.org/10.1002/art.39020

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Ekman I, Ihantola EL, Viisanen T, Rao DA, Näntö-Salonen K, Knip M et al (2019) Circulating CXCR5(-)PD-1(hi) peripheral T helper cells are associated with progression to type 1 diabetes. Diabetologia 62:1681–1688. https://doi.org/10.1007/s00125-019-4936-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. (2018) 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care 41: S13-s27. https://doi.org/10.2337/dc18-S002

  23. American Diabetes A (2018) 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care 41:S13–S27. https://doi.org/10.2337/dc18-S002

    Article  Google Scholar 

  24. Zhu M, Xu K, Chen Y, Gu Y, Zhang M, Luo F et al (2019) Identification of Novel T1D Risk Loci and Their Association With Age and Islet Function at Diagnosis in Autoantibody-Positive T1D Individuals: Based on a Two-Stage Genome-Wide Association Study. Diabetes Care 42:1414–1421. https://doi.org/10.2337/dc18-2023

    Article  CAS  PubMed  Google Scholar 

  25. Xu B, Wang S, Zhou M, Huang Y, Fu R, Guo C et al (2017) The ratio of circulating follicular T helper cell to follicular T regulatory cell is correlated with disease activity in systemic lupus erythematosus. Clin Immunol 183:46–53. https://doi.org/10.1016/j.clim.2017.07.004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Xu X, Shen M, Zhao R, Cai Y, Jiang H, Shen Z et al (2019) Follicular regulatory T cells are associated with beta-cell autoimmunity and the development of type 1 diabetes. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2019-00093

    Article  PubMed  PubMed Central  Google Scholar 

  27. Force CMaGoCoT (2002) Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chin J Epidemiol 23:6

    Google Scholar 

  28. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Becker DJ, Gitelman SE, Goland R et al (2009) Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 361:2143–2152. https://doi.org/10.1056/NEJMoa0904452

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Manzo A, Vitolo B, Humby F, Caporali R, Jarrossay D, Dell’accio F et al (2008) Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint. Arthritis Rheum 58:3377–3387. https://doi.org/10.1002/art.23966

    Article  CAS  PubMed  Google Scholar 

  30. Wu EL, Kazzi NG, Lee JM (2013) Cost-effectiveness of screening strategies for identifying pediatric diabetes mellitus and dysglycemia. JAMA Pediatr 167:32–39. https://doi.org/10.1001/jamapediatrics.2013.419

    Article  PubMed  Google Scholar 

  31. Christophersen A, Lund EG, Snir O, Sola E, Kanduri C, Dahal-Koirala S et al (2019) Distinct phenotype of CD4(+) T cells driving celiac disease identified in multiple autoimmune conditions. Nat Med 25:734–737. https://doi.org/10.1038/s41591-019-0403-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Smith FL, Baumgarth N (2019) B-1 cell responses to infections. Curr Opin Immunol 57:23–31. https://doi.org/10.1016/j.coi.2018.12.001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Cencioni MT, Mattoscio M, Magliozzi R, Bar-Or A, Muraro PA (2021) B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies. Nat Rev Neurol 17:399–414. https://doi.org/10.1038/s41582-021-00498-5

    Article  PubMed  Google Scholar 

  34. Sahputra R, Ruckerl D, Couper KN, Muller W, Else KJ (2019) The Essential Role Played by B Cells in Supporting Protective Immunity Against Trichuris muris Infection Is by Controlling the Th1/Th2 Balance in the Mesenteric Lymph Nodes and Depends on Host Genetic Background. Front Immunol 10:2842. https://doi.org/10.3389/fimmu.2019.02842

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Khan IM, Perrard XY, Brunner G, Lui H, Sparks LM, Smith SR et al (2015) Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance. Int J Obes (Lond) 39:1607–1618. https://doi.org/10.1038/ijo.2015.104

    Article  CAS  PubMed  Google Scholar 

  36. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M et al (2009) CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15:914–920. https://doi.org/10.1038/nm.1964

    Article  CAS  PubMed  Google Scholar 

  37. Shimobayashi M, Albert V, Woelnerhanssen B, Frei IC, Weissenberger D, Meyer-Gerspach AC et al (2018) Insulin resistance causes inflammation in adipose tissue. J Clin Invest 128:1538–1550. https://doi.org/10.1172/JCI96139

    Article  PubMed  PubMed Central  Google Scholar 

  38. Winer DA, Winer S, Chng MH, Shen L, Engleman EG (2014) B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance. Cell Mol Life Sci 71:1033–1043. https://doi.org/10.1007/s00018-013-1486-y

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was supported by grants from the National Natural Science Foundation of China (number 81970707, 82270875,82230028).

Author information

Authors and Affiliations

Authors

Contributions

ZS and XX performed the experiments. YC, CM and YG provided the clinical samples. RZ and YJ were responsible for the analyses of diabetes-associated autoantibodies. ZS and XX analyzed the data and drafted the manuscript. All authors contributed to the final version of the manuscript. TY and XX are the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Corresponding authors

Correspondence to Tao Yang or Xinyu Xu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Statement of human and animal rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Local Ethics Committee of First Affiliated Hospital of Nanjing Medical University.

Informed consent

The study was based on the collection of data generated by observation and follow-up study of immunological markers in patients with type 1 diabetes and first-degree relatives. Thus, informed consent was signed.

Additional information

Managed By Antonio Secchi.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Fig. S1

Representative dot plot showing the gating strategy for Tfh cells and FOXP3+CXCR5+PD-1+Tfr cells. (TIF 4346 KB)

Supplementary Fig. S2

The frequency of circulating Tph cells did not correlate with (A) B cells but did correlate with the frequency of (B) Tfh cells and (C) FOXP3+CXCR5+PD-1+ Tfr cells in T2DM patients (n = 92). The frequency of circulating Tph cells was positively correlated with the frequency of (D) B cells, (E) Tfh cells and (F) FOXP3+CXCR5+PD-1+ Tfr cells in T1DM patients (n = 106). Correlations between circulating CXCR5-PD-1hi Tph cells and PD-1+Tfh/Tfr ratio in patients with (G) T2DM (n = 92) and (J) T1DM (n=106). Correlations between circulating Tph cells and FOXP3+CXCR5+ICOS+ Tfr cells in patients with (H) T2DM (n = 92) and (K) T1DM (n = 106). Correlations between Tph cells and Treg cells in (I) T2DM (n = 92) and (L) T1DM patients (n = 106). (TIF 4464 KB)

Supplementary Fig. S3

(A–C) Correlations between circulating Tph cells and (A) BMI, (B) B cells, (C) Tfh cells and (D) FOXP3+CXCR5+PD-1+ Tfr cells in normal weight T2DM patients (n = 33). (E–F) Correlations between circulating Tph cells and FOXP3+CXCR5+ICOS+ Tfr cells in (E) normal weight T2DM patients (n = 33) and (F) overweight T2DM patients (n = 59). (TIF 2174 KB)

Supplementary Fig. S4

(A–C) Correlation between circulating Tph cells and the levels of (A) C-PAUC, (B) fasting blood glucose and (C) HbA1c in normal weight T2DM patients (n = 33). (D–E) Correlations between circulating Tph cells and fasting serum C-peptide in (D) overweight T2DM patients (n = 59) and (E) normal weight T2DM patients (n = 33). (F) Correlation between circulating Tph cells and disease course in T2DM patients (n = 92). (G–H) Correlations between circulating Tph cells and HOMA-IR in (G) T2DM patients, (H) overweight T2DM patients (n = 59) and (I) normal weight T2DM patients (n = 33). (TIF 2916 KB)

Supplementary Fig. S5

(A–D) Correlation between the frequency of circulating Tph cells and (A) the level of C-P (n = 68), (B) C-PAUC (n = 53), (C) fasting blood glucose (n = 66) and (D) HbA1c (n = 96) in T1DM patients. (E–F) Correlation between the frequency of circulating Tph cells and (E) disease duration (n = 84) and (F) daily insulin dose in T1DM patients (n = 91). (TIF 2902 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Su, Z., Ma, C., Zhao, R. et al. Heterogeneity of circulating CXCR5-PD-1hiTph cells in patients of type 2 and type 1 diabetes in Chinese population. Acta Diabetol 60, 767–776 (2023). https://doi.org/10.1007/s00592-023-02055-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-023-02055-6

Keywords

Navigation